Now it was almost a year since the beginning of the media storm around the discovery by Dr. Pablo Zamboni and cerebrospinal fluid of chronic venous insufficiency, and there are various reports and the results achieved on a new therapy called Liberation . There are strong proponents and activists as a strong anti CCIVS CCIVS. Some new tests were also conducted to test this theory and further tests are required. The patient should be treated push hard, and some influential people in the government calling for more research in this area, and some doctors. Patients are on blogs, websites and social experiences and outcomes for ‘Liberation’ reporting. Now please do not shoot the messenger, but the messenger is to read what is there and his interpretation that there is an objective opinion. The review of the messenger is there a place for CCIVS in multiple sclerosis and we can surely benefit, but to what extent, I do not know, but my hopes are high that the time will increase the quality of life for some of us. Whether it’s a cure I think time will tell, but I do not label as such, but a complication and a possible new treatment for multiple sclerosis, especially in the initial phase. Are we seeing a new cause of disease, vascular diseases and autoimmune diseases? Has I think it is too early to conclude that multiple has sclerosis all marks of the classical autoimmune diseases and research to achieve revealed this fact during most of the last fifty years . But it could be a new complication to the course of the disease in many patients can influence. vascular connection has been studied in the past 50 years, but never made an interesting discovery.
For those who happen to lose all the hype is for CCIVS Liquor chronic venous insufficiency. The theory is that multiple sclerosis are jugular veins in the neck and the azygos vein drainage of the spinal cord narrowed or blocked, causing a backup of the oxygen-poor blood to the brain. It is assumed that this is the cause of reflux iron accumulation in the brain, leading to complications in or behind of multiple sclerosis. This phenomenon was developed by Dr. Paulo Zambrano in Italy, a vascular surgeon, whose wife discovered diagnosed with multiple sclerosis. Treatment consists of the release of balloon angioplasty, namely the veins enlarged by blowing up a balloon to open a vein. Since then, some vascular surgeons worldwide offer this treatment, some even with the use of stents, a device that is placed into the vein to keep it open. Mr. Zamboni recommend the use of stents. Note also that it remains unclear whether the new definitive treatment, hence his appeal to patients in their disease-modifying drugs before they can be proven.
CCIVS has an important role in multiple sclerosis play, and some patients reported improvement in symptoms is a very good sign for this important new development. Most patients with relapsing-remitting multiple sclerosis report a good measure of the improvement and the weight of this new theory. In the case of progressive multiple sclerosis (SPMS and PPMS), the improvement is not as big, with more benefits with little or nothing, but it is expected a little, that the damage it can cause and MS is very wide with nerve endings in the brain, spinal cord permanently damage or loss. We could use a new era in the treatment of multiple sclerosis, especially for new patients in the early stages of MS and this new treatment diagnosed a new promise to stop the progression of the disease, and may even benefit from our veterans, too.
However, the lack of long-term results shed more light on the subject, but it is not surprising, since a new medical treatment, in the time of 2-20 years to prove or disprove. Patients are angry, this treatment will now wait and wait and do not want, but it is expected that multiple sclerosis, a disease that causes the fear in a person with their lives. This has enabled organizations to attract me to rest until this theory was proved or disproved, as such, but a disease that is based on fear, that patients around the world that flew contributed to this treatment. This is also expected and in my opinion, feel some patients, that this is the last hope, and we can not blame them because they have a future with the likelihood of invalid or is already disabled multiple sclerosis face. Preliminary reports show that certainly in relapsing multiple sclerosis running multiple benefit and to a lesser extent, the group of progressive multiple sclerosis (PPMS or SPMS). Identification as a placebo effect seems a bit far and his characters are larger studies justified.
Now the big question: Is the theory hold or will die a thousand deaths at the end of an investigation. My opinion is now undoubtedly benefit some patients, but security can be complications of treatment. Search all pages of the patients are not signs that a new form could have the treatment of multiple sclerosis, but at this stage it is only a treatment that can improve the quality of life for some patients and the disease can sometimes slow. Mr. Zamboni first figures show that about 50% of jugular veins and azygos not fall again in the first year and 18 months. Since most of their results are published in patients with relapsing-remitting multiple sclerosis is unclear whether this refers to the natural history of multiple sclerosis is. Most patients tend to RRMS very little during the first 50-10 years after the onset of multiple sclerosis relapse and can go without a relapse for a long time. But he adds that these figures show a success rate of around 27% of their group. But what is this percentage? If these patients without recurrence for 3 years or more to go? These are questions that can not be released by long-term studies and the results achieved.
Read all the pages, it appears that most patients showed an improvement of the brain fog, vision and energy and balance of information and improvement of the March. Improved Disability Status Scale reported extended report in about 1 point, but again there are reports and patient medical records are not real. The most remarkable is the feeling of warm hands and feet immediately after liberation. Some patients report little or no improvement, with some reports of improvements after only a few weeks. Most patients reported no relapses, but some do, and in some cases due to the collapse of the veins. Some cases can not return to the collapse or narrowing of the veins of the new patients who reported no restenosis of the vein found and links it seems that may fall into this stage without streaks restenosis. Unfortunately, there are also reports to be worse after the procedure and something to this concern. This is not disclosed by CCIVS defender explained, but the reports can be found and it is a matter of finding them. Are rare, but they are still there.
However, it is also the other side of the reports, it sounds a little far-fetched, but they are very few reports of patients and do not know whether to believe it with a pinch of salt, or refer to refer to real improvements. I am not inclined to point blank shot, but these, but some reports of patients from their wheelchairs and walk tends to be a little air on the safe side leave. With multiple sclerosis, a large part of the muscular atrophy is a major cause for the patients are in a wheelchair, and a release will not lead to stand and walk immediately after. These patients take weeks physical therapy to walk again, the muscle strength back. This is evident in patients with brain damage and spinal cord that temporary disability and need physical therapy to improve strength in the legs and can walk again. The only conclusion drawn from this assumption, and I apologize for very directly to the question here and maybe look sensualisation care for these patients. In all cases, the share is not a miracle that can walk again because it is run against the medical tests. This can not be accepted if in case the patient underwent physical therapy later, but results in a new question. Is this a case of practice, the force or actual force from the increased exemption again? This is another problem that must be answered by further studies. To return to the feeling of warm hands and feet, it was dismissed by Dr. Simkins CCIVS a pioneer in the field can be an effect of angiotensin. Angiotensin II is responsible for body temperature and impaired blood flow to increase the brain, that would explain the feeling of warm hands and feet. Concerning the general feeling of well-being as a direct result could be the liberation and the repair of blood in the brain, stopping the flow of oxygen-poor blood to the brain. But here we have a lot of studies in this area, such as angiotensin may have a role to play in this also. This is not just my feeling, but it is also the feeling of Mr. Simkins. Fatigue in multiple sclerosis is still a little known cause, and correct the flow of blood into the ventricles of the brain could certainly reported an impact on this problem, but the fact that some patients have an immediate improvement in the brain fog and power immediately after the release procedure and can not be attributed to the effects of angiotensin well. Correct the blood flow is not immediate removal of all excess iron and immediate repair of damage caused by multiple sclerosis, but take a few weeks for a change. The change in the volume of blood flow can alter or improve the function of the hypothalamus of the brain that is responsible for most of the production of neuro-hormonal. This could lead to increased ACTH, ADH, and neuro-pinephrine dopamine levels that lead to feelings of well-being. But a large percentage of patients with the procedure eventually lose this feeling, without restenosing after a few months. Some patients report feeling a new life and energy rose only a few weeks, and this could be interpreted as a direct result of the treatment of liberation. A direct consequence of the treatment, so that balance, gait and strength improved after a few weeks in some patients.
Finally the question: Is it safe and without complications in the long run? Balloon angioplasty is relatively safe, and it is a rare complication reported. When you add on the U.S. national figures for angioplasty drive, a 6.2% rate of serious complications, some resulting in death, but I have that this figure is based on all angioplasty, and most of these complications in heart and stroke. However, it appears that the complication rate is much lower CCIVS that the procedure is more on the venous side and not the arterial side. The first report is what’s tragic to a migration of the stent open heart surgery, and Holly’s death. Holly’s death was not due to a stroke and as a result of the procedure, but the complication was enough for Stanford to do the procedure. But new reports have surfaced in several places in which multiple blood clots in some patients, and in some cases, the clot is severe enough to cause or pulmonary embolism or stroke. Fortunately, he was caught in time and patients were spared a serious complication. Most of these tissues were reported patients had stents implanted. A further complication has arisen, the closure of the stent and three cases of open-neck surgery was necessary to remove the prosthesis and the Web. In other cases, the stent was successfully opened by re-angioplasty. But this is serious enough for further studies on the use of stents, etc. A further complication is the arrest rate of in-stent restenosis can not be used continuously and balloons can eventually lead to more complications.
With all that being said, there is a clear need for further investigations and proceedings CCIVS to correct this. As mentioned by Dr. Simkins, CCIVS is not the direct cause of multiple sclerosis, but CCIVS and other factors. In my mind that the ultimate theory that MS is an autoimmune disease and CCIVS is rather a complication of the disease and not its cause. The treatment can safely benefit from CCIVS most patients with relapsing-remitting multiple sclerosis or supplement the current process as we know. I believe we have to wait for the next series of tests that currently needs before jumping to conclusions on this important discovery. Hopefully it will take at least a better understanding of multiple sclerosis or deceived by some the mysterious disease , and keep intact the messenger, as he still may be something important to say.
Now it was almost a year since the beginning of the media storm around the discovery by Dr. Pablo Zamboni and cerebrospinal fluid of chronic venous insufficiency, and there are various reports and the results achieved on a new therapy called Liberation . There are strong proponents and activists as a strong anti CCIVS CCIVS. Some new tests were also conducted to test this theory and further tests are required. The patient should be treated push hard, and some influential people in the government calling for more research in this area, and some doctors. Patients are on blogs, websites and social experiences and outcomes for ‘Liberation’ reporting. Now please do not shoot the messenger, but the messenger is to read what is there and his interpretation that there is an objective opinion. The review of the messenger is there a place for CCIVS in multiple sclerosis and we can surely benefit, but to what extent, I do not know, but my hopes are high that the time will increase the quality of life for some of us. Whether it’s a cure I think time will tell, but I do not label as such, but a complication and a possible new treatment for multiple sclerosis, especially in the initial phase. Are we seeing a new cause of disease, vascular diseases and autoimmune diseases? Has I think it is too early to conclude that multiple has sclerosis all marks of the classical autoimmune diseases and research to achieve revealed this fact during most of the last fifty years . But it could be a new complication to the course of the disease in many patients can influence. vascular connection has been studied in the past 50 years, but never made an interesting discovery.
For those who happen to lose all the hype is for CCIVS Liquor chronic venous insufficiency. The theory is that multiple sclerosis are jugular veins in the neck and the azygos vein drainage of the spinal cord narrowed or blocked, causing a backup of the oxygen-poor blood to the brain. It is assumed that this is the cause of reflux iron accumulation in the brain, leading to complications in or behind of multiple sclerosis. This phenomenon was developed by Dr. Paulo Zambrano in Italy, a vascular surgeon, whose wife discovered diagnosed with multiple sclerosis. Treatment consists of the release of balloon angioplasty, namely the veins enlarged by blowing up a balloon to open a vein. Since then, some vascular surgeons worldwide offer this treatment, some even with the use of stents, a device that is placed into the vein to keep it open. Mr. Zamboni recommend the use of stents. Note also that it remains unclear whether the new definitive treatment, hence his appeal to patients in their disease-modifying drugs before they can be proven. CCIVS has an important role in multiple sclerosis play, and some patients reported improvement in symptoms is a very good sign for this important new development. Most patients with relapsing-remitting multiple sclerosis report a good measure of the improvement and the weight of this new theory. In the case of progressive multiple sclerosis (SPMS and PPMS), the improvement is not as big, with more benefits with little or nothing, but it is expected a little, that the damage it can cause and MS is very wide with nerve endings in the brain, spinal cord permanently damage or loss. We could use a new era in the treatment of multiple sclerosis, especially for new patients in the early stages of MS and this new treatment diagnosed a new promise to stop the progression of the disease, and may even benefit from our veterans, too. However, the lack of long-term results shed more light on the subject, but it is not surprising, since a new medical treatment, in the time of 2-20 years to prove or disprove. Patients are angry, this treatment will now wait and wait and do not want, but it is expected that multiple sclerosis, a disease that causes the fear in a person with their lives. This has enabled organizations to attract me to rest until this theory was proved or disproved, as such, but a disease that is based on fear, that patients around the world that flew contributed to this treatment. This is also expected and in my opinion, feel some patients, that this is the last hope, and we can not blame them because they have a future with the likelihood of invalid or is already disabled multiple sclerosis face. Preliminary reports show that certainly in relapsing multiple sclerosis running multiple benefit and to a lesser extent, the group of progressive multiple sclerosis (PPMS or SPMS). Identification as a placebo effect seems a bit far and his characters are larger studies justified.
Now the big question: Is the theory hold or will die a thousand deaths at the end of an investigation. My opinion is now undoubtedly benefit some patients, but security can be complications of treatment. Search all pages of the patients are not signs that a new form could have the treatment of multiple sclerosis, but at this stage it is only a treatment that can improve the quality of life for some patients and the disease can sometimes slow. Mr. Zamboni first figures show that about 50% of jugular veins and azygos not fall again in the first year and 18 months. Since most of their results are published in patients with relapsing-remitting multiple sclerosis is unclear whether this refers to the natural history of multiple sclerosis is. Most patients tend to RRMS very little during the first 50-10 years after the onset of multiple sclerosis relapse and can go without a relapse for a long time. But he adds that these figures show a success rate of around 27% of their group. But what is this percentage? If these patients without recurrence for 3 years or more to go? These are questions that can not be released by long-term studies and the results achieved.
Read all the pages, it appears that most patients showed an improvement of the brain fog, vision and energy and balance of information and improvement of the March. Improved Disability Status Scale reported extended report in about 1 point, but again there are reports and patient medical records are not real. The most remarkable is the feeling of warm hands and feet immediately after liberation. Some patients report little or no improvement, with some reports of improvements after only a few weeks. Most patients reported no relapses, but some do, and in some cases due to the collapse of the veins. Some cases can not return to the collapse or narrowing of the veins of the new patients who reported no restenosis of the vein found and links it seems that may fall into this stage without streaks restenosis. Unfortunately, there are also reports to be worse after the procedure and something to this concern. This is not disclosed by CCIVS defender explained, but the reports can be found and it is a matter of finding them. Are rare, but they are still there.
However, it is also the other side of the reports, it sounds a little far-fetched, but they are very few reports of patients and do not know whether to believe it with a pinch of salt, or refer to refer to real improvements. I am not inclined to point blank shot, but these, but some reports of patients from their wheelchairs and walk tends to be a little air on the safe side leave. With multiple sclerosis, a large part of the muscular atrophy is a major cause for the patients are in a wheelchair, and a release will not lead to stand and walk immediately after. These patients take weeks physical therapy to walk again, the muscle strength back. This is evident in patients with brain damage and spinal cord that temporary disability and need physical therapy to improve strength in the legs and can walk again. The only conclusion drawn from this assumption, and I apologize for very directly to the question here and maybe look sensualisation care for these patients. In all cases, the share is not a miracle that can walk again because it is run against the medical tests. This can not be accepted if in case the patient underwent physical therapy later, but results in a new question. Is this a case of practice, the force or actual force from the increased exemption again? This is another problem that must be answered by further studies. To return to the feeling of warm hands and feet, it was dismissed by Dr. Simkins CCIVS a pioneer in the field can be an effect of angiotensin. Angiotensin II is responsible for body temperature and impaired blood flow to increase the brain, that would explain the feeling of warm hands and feet. Concerning the general feeling of well-being as a direct result could be the liberation and the repair of blood in the brain, stopping the flow of oxygen-poor blood to the brain. But here we have a lot of studies in this area, such as angiotensin may have a role to play in this also. This is not just my feeling, but it is also the feeling of Mr. Simkins. Fatigue in multiple sclerosis is still a little known cause, and correct the flow of blood into the ventricles of the brain could certainly reported an impact on this problem, but the fact that some patients have an immediate improvement in the brain fog and power immediately after the release procedure and can not be attributed to the effects of angiotensin well. Correct the blood flow is not immediate removal of all excess iron and immediate repair of damage caused by multiple sclerosis, but take a few weeks for a change. The change in the volume of blood flow can alter or improve the function of the hypothalamus of the brain that is responsible for most of the production of neuro-hormonal. This could lead to increased ACTH, ADH, and neuro-pinephrine dopamine levels that lead to feelings of well-being. But a large percentage of patients with the procedure eventually lose this feeling, without restenosing after a few months. Some patients report feeling a new life and energy rose only a few weeks, and this could be interpreted as a direct result of the treatment of liberation. A direct consequence of the treatment, so that balance, gait and strength improved after a few weeks in some patients.
Finally the question: Is it safe and without complications in the long run? Balloon angioplasty is relatively safe, and it is a rare complication reported. When you add on the U.S. national figures for angioplasty drive, a 6.2% rate of serious complications, some resulting in death, but I have that this figure is based on all angioplasty, and most of these complications in heart and stroke. However, it appears that the complication rate is much lower CCIVS that the procedure is more on the venous side and not the arterial side. The first report is what’s tragic to a migration of the stent open heart surgery, and Holly’s death. Holly’s death was not due to a stroke and as a result of the procedure, but the complication was enough for Stanford to do the procedure. But new reports have surfaced in several places in which multiple blood clots in some patients, and in some cases, the clot is severe enough to cause or pulmonary embolism or stroke. Fortunately, he was caught in time and patients were spared a serious complication. Most of these tissues were reported patients had stents implanted. A further complication has arisen, the closure of the stent and three cases of open-neck surgery was necessary to remove the prosthesis and the Web. In other cases, the stent was successfully opened by re-angioplasty. But this is serious enough for further studies on the use of stents, etc. A further complication is the arrest rate of in-stent restenosis can not be used continuously and balloons can eventually lead to more complications.
With all that being said, there is a clear need for further investigations and proceedings CCIVS to correct this. As mentioned by Dr. Simkins, CCIVS is not the direct cause of multiple sclerosis, but CCIVS and other factors. In my mind that the ultimate theory that MS is an autoimmune disease and CCIVS is rather a complication of the disease and not its cause. The treatment can safely benefit from CCIVS most patients with relapsing-remitting multiple sclerosis or supplement the current process as we know. I believe we have to wait for the next series of tests that currently needs before jumping to conclusions on this important discovery. Hopefully it will take at least a better understanding of multiple sclerosis or deceived by some the mysterious disease , and keep intact the messenger, as he still may be something important to say.